Neurology CRO: Key Challenges in CNS Clinical Trials Neurology clinical trials present distinct challenges for drug developers, from patient recruitment and retention to endpoint variability, placebo response, and long study durations. These factors can complicate trial execution and make reliable assessment of treatment effects particularly difficult. For sponsors developing therapies for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, and other neurological conditions, selecting Read more
Top 2025 clinical trials
2025’s Top Clinical Trials: Closing a Transformative Year in Medicine 2025 was not a year of merely “positive” trials. It was a year defined by effect sizes, first-line shifts, and disease-modifying signals that are already changing real clinical decision-making. Across oncology, cardiometabolic disease, liver and rare disorders, several late-stage readouts stood out not because they met endpoints, but because they reset expectations — introducing new standards of Read more
Clinical Research Focus. 48th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of January 2026. Read more
The Most Transformative FDA Approvals of 2025 | Cromos Pharma
The Most Transformative FDA Approvals of 2025: Therapies Redefining Clinical Research and Future Trial Strategy FDA approvals have always reflected scientific progress, but the 2025 roster does more than showcase innovation — it captures the rapidly changing nature of clinical trials themselves. This year’s approvals highlight how development programs are becoming more precise, more data-driven, and more tightly aligned with molecular insights that reshape traditional trial models. Across oncology, hematology, Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us